司太立：关于全资子公司获得药品注册证书的公告

Core Viewpoint - The company has received approval from the National Medical Products Administration for the marketing of Gadopentetic Acid Injection, indicating a significant milestone in its product development and regulatory compliance [1]. Group 1 - The company, Zhejiang Sitaili Pharmaceutical Co., Ltd., announced that its wholly-owned subsidiary, Shanghai Sitaili Pharmaceutical Co., Ltd., has obtained the drug registration certificate for Gadopentetic Acid Injection [1].